dazmegrel has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirschfeld, DR; Maloney, PJ; Martinez, GR; Rosenkranz, RP; Walker, KA; Yang, DS | 1 |
| Brown, PI; Nicoll, DW; Rankin, GO; Teets, VJ; Valentovic, MA | 1 |
| Archer, RL; Bliven, ML; Cunningham, AC; Moore, PF; Otterness, IG; Potter, JA | 1 |
3 other study(ies) available for dazmegrel and Kidney Diseases
| Article | Year |
|---|---|
[(1H-imidazol-1-yl)methyl]- and [(3-pyridinyl)methyl]pyrroles as thromboxane synthetase inhibitors.
Topics: Animals; Aorta; Biological Availability; Blood Platelets; Chemical Phenomena; Chemistry; Humans; Imidazoles; Inflammation; Kidney Diseases; Male; Mice; Microsomes; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Pyridines; Pyrroles; Rats; Structure-Activity Relationship; Swine; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1989 |
Autacoid modulation and N-(3,5-dichlorophenyl)succinimide nephrotoxicity.
Topics: Animals; Creatinine; Fungicides, Industrial; Hemodynamics; Imidazoles; Indomethacin; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred F344; Succinimides; Thromboxane-A Synthase; Time Factors | 1990 |
Effects of dazmegrel, piroxicam and cyclophosphamide on the NZB/W model of SLE.
Topics: Animals; Body Weight; Cyclophosphamide; Female; Imidazoles; Kidney Diseases; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphocytes; Mice; Piroxicam; Proteinuria; Thromboxane-A Synthase; Time Factors | 1989 |